$100.00Original price was: $100.00.$92.40Current price is: $92.40.
CJC-1295 causes the natural release of GH, but it does so by naturally stimulating the growth hormone releasing hormone receptor.
Ipamorelin is one of the most selective growth hormone (GH) secretagogues known and a potent agonist of the ghrelin/growth hormone secretagogue receptor. It has been heavily researched in a number of settings and is known to, improve bone health, boost muscle repair and development, stimulate insulin release from the pancreas, and improve bowel motility and gastric function.
CJC-1295 when combined with Ipamorelin has been shown to exhibit synergistic effects when researched together.
This synergistic peptide blend combines two powerful growth hormone secretagogues, and dosing should be titrated based on user response and clinical goals. A standard starting dose is 0.5 ml (0.5 mg CJC-1295 + 0.5 mg Ipamorelin) administered once daily, preferably at night before sleep. This can be increased to 1 ml per dose over time (1 mg of each peptide), depending on tolerance and results.
A typical escalation protocol might look like:
Week 1–2: 0.5 ml (0.5 mg of each peptide) once daily
Week 3–4: Increase to 0.75 ml per day
Week 5+: 1 ml daily or 1 ml every other day, depending on long-term goals
This blend is ideally administered once daily in the evening to align with the natural growth hormone rhythm. For more aggressive protocols, some practitioners recommend 5–7 days per week use for 8–12 weeks, followed by a rest period or taper.
This combination of CJC-1295 with DAC and Ipamorelin offers a potent, balanced approach to enhancing endogenous growth hormone (GH) and IGF-1 production. While CJC-1295 (a GHRH analog) increases GH pulse amplitude and half-life, Ipamorelin (a GHRP) increases pulse frequency and intensity. Together, they work synergistically to mimic the body’s natural growth hormone pulsatility without disrupting feedback loops or causing excessive side effects.
This blend is commonly used to support:
Muscle recovery and lean mass development
Fat loss and metabolic enhancement
Anti-aging and sleep quality
Tissue repair, collagen synthesis, and joint health
This combination works via dual stimulation of the growth hormone axis:
CJC-1295 with DAC binds to GHRH receptors, stimulating the anterior pituitary to release GH in prolonged pulses. DAC technology extends the half-life to ~8–10 days by binding to albumin.
Ipamorelin binds to the ghrelin receptor (GHSR-1a), triggering rapid GH release with minimal impact on cortisol or prolactin levels.
Together, they:
Enhance both amplitude and frequency of GH pulses
Stimulate hepatic IGF-1 production
Promote anabolism, cellular regeneration, and fat metabolism
Support neuroprotective and cardiovascular health through GH/IGF-1 modulation
This peptide combination is not recommended for use during pregnancy or lactation. Due to its hormonal effects and lack of safety data in these populations, it should be avoided entirely during these periods.
While GH secretagogues may be used in clinically diagnosed GH deficiency, this blend is not approved for pediatric use and should only be considered under the care of a pediatric endocrinologist. Off-label use in children is not recommended.
